Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

3.49
Delayed Data
As of Jul 31
 +0.01 / +0.29%
Today’s Change
1.51
Today|||52-Week Range
9.50
+67.79%
Year-to-Date

Today’s Trading

Previous close3.48
Today’s open3.46
Day’s range3.41 - 3.52
Volume48,742
Average volume (3 months)317,545
Market cap$23.5M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+18.03%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book19.37

Competitors

 Today’s
change
Today’s
% change
PRPHProPhase Labs Inc0.000.00%
CYCCCyclacel Pharmaceuti...+0.02+3.08%
CLRBCellectar Bioscience...-0.19-5.78%
ABIOARCA Biopharma Inc-0.12-9.70%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$6.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Iain Gladstone Ross
COO, Head-Administration &
Finance
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts